R Londoõ
Abstract
The combination of L-dopa with carbidopa was administered to 18 patients with ediopathic Parkinson's disease and the dose needed to control the manifestations, either partially or completely, with the least number of side effects, was established.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The combination of L-dopa with carbidopa was administered to 18 patients with ediopathic Parkinson's disease and the dose needed to control the manifestations, either partially or completely, with the least number of side effects, was established.
Key concepts: Carbidopa, Levodopa, Decarboxylase inhibitor, Parkinson's disease, Aromatic L-amino acid decarboxylase, Medicine, Disease, Pharmacology